Rising Diabetes Cases Push Demand for Foot Ulcer Treatments Worldwide
The global diabetic foot ulcer (DFU) therapeutics market is poised for steady growth, with its valuation projected to rise from US$ 7,578.5 million in 2025 to US$ 11,246.8 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.8% during the forecast period. This growth underscores the expanding burden of diabetes-related complications globally, particularly the increasing incidence of diabetic foot ulcers.

Understanding Diabetic Foot Ulcers
A diabetic foot ulcer is an open sore or wound that typically occurs on the bottom of the foot in patients with diabetes mellitus. This condition arises due to the interplay of peripheral neuropathy, peripheral arterial disease, and poor glycemic control, which impair wound healing and immune function. If left untreated, DFUs can lead to severe infections, gangrene, and eventually, lower-limb amputations, representing a critical health challenge worldwide.
Epidemiological Insights
According to Persistence Market Research, approximately 20% of individuals with type 2 diabetes will…